Abstract: Aromatic amino acid ammonia-lyasesa nd aromatic amino acid 2,3-aminomutases contain the post-translationally formed prosthetic 3,5-dihydro-4-methylidene-5H-imidazol-5-one (MIO)g roup.M IO enzymesc atalyze the stereoselective synthesiso faor b-aminoa cid enantiomers,m aking these chemical processese nvironmentally friendly anda ffordable. Characterizationo fn ovel inhibitors enables structural understanding of enzyme mechanisma nd recognizes promising herbicide candidates as well. The presents tudy found that bothe nantiomers of the aminophosphonica cid analogue of the natural substrate phenylalanine andanovel derivativeb earing am ethylidenea tt he b-position inhibited phenylalanine ammonia-lyases (PAL), representing MIO enzymes.X -ray methodsu nambiguously determined the absolute configuration of all testede nantiomers during their synthesis.E nzyme kinetic measurements revealedt he enantiomero ft he methylidene-substituted substrate analogue as being am irror image relation to the natural l-phenylalanine as the strongest inhibitor. Isothermal titrationc alorimetry (ITC) confirmedt he binding constants and provided ad etailed analysis of the thermodynamic drivingf orces of ligand binding. Moleculard ocking suggested that binding of the (R)-and( S)-enantiomers is possible by amirror image packing.
Introduction
Phenylalanine ammonia-lyasesc atalyze the non-oxidative ammonia elimination from l-phenylalaninet o yield (E)-cinnamic acid [(E)-CA]. [1] They are most commonly found in fungi and plants,w here cinnamic acid is the starting material for the biosynthesis of an array of natural productsr anging from flavonoids to lignins. [2] Industrial applications make use of the reverse reactionf or the synthesis of unnatural amino acids.I n1 983, Genex Corporation patented am ethod for the enzymatic production of l-phenylalanine, one of the components of the artificial sweetenerd ipeptide aspartame. [3] Currently PA Ls are more widely used for the synthesis of unnatural amino acids. [4] DSM Pharma Chemicals developedamethod based on PAL-catalyzedh ydroaminationo f2 '-chlorocinnamic acid for the production of (S)-2-indolinecarboxylic acid on the ton scale. [5] Related and structurallysimilarenzymes are l-tyrosine (TAL) [6] and l-histidine ammonia-lyases (HAL) [7] and l-tyrosine (TAM) [8] and l-phenylalanine 2,3-amino-mutases (PAM). [9] These enzymesa ll contain in their catalytic centers the 3,5-dihydro-4-methylidene-5H-imidazol-5-one (MIO) electrophilic prosthetic group.T his uncommon cofactori sf ormed in an autocatalytic way in ap osttranslational process from three adjacent amino acids of the respective protein beingu sually alanine-serine-glycineb yc yclization and dehydration. [10] In spiteo ft he relatively lows imilarity betweentheir sequences(< 30%),the tertiary andquaternaryf olds of allM IO-containingp roteinsa re highly similar. Mutagenesiss tudies showed that twot yrosines (Tyr A andT yr B in Scheme 1) aree ssential forc atalysis in HAL, [11] PA L, [12] andT AL. [13] Theses tructurals imilarities suggestt hata mmonia eliminationp roceedsb y similarmechanismsina ll MIO enzymes.
Threem echanisms have been proposedf or the enzymatic elimination of ammonia involving MIO (Scheme 1).
The N-MIO intermediate mechanism suggestst hat the amino group of the substrate forms ac ovalent bond with the electrophilic MIO residue of the enzyme,t hat generates ab etter leaving group (Scheme 1A, N-MIO intermediate pathway). Most likely,a mmonia elimination from the covalent intermediatep roceeds by as tepwise process via ac arbanion intermediate (E 1 cB mechanism). [14] As the abstraction of the non-acidic b-protonw as consideredt ob ed ifficult by an amino acid base, aF riedel-Crafts (FC)-type mechanism was proposed (Scheme 1B). The b-hydrogens of phenylalanine could be acidifiedb yt he positive charge in the forming s-complex. Thus Ty r A can deprotonate the b-position with concomitant elimination of the protonated amino group as NH 3 .A tl ast, the releaseo fM IO restores the aromaticity. [15] Recently,asingle-step mechanism was proposed for TAL. It assumes as ingle transitions tate (TS) for the deamination without the formation of ac ovalent bond between the substrate andt he MIO group (Scheme 1C). [16] Althoughs ome questions remain open about the mechanism of action of MIO-enzymes, kinetic isotope effect studies, [17] crystallographic data [18] and computational studies [19] support the N-MIO mechanism. PA Ls show high enantioselectivity in the catalysis of their natural substrate l-phenylalanine andi ts analogues,b ut are also capable of binding the d-enantiomers.I tw as found that PA Lc ouldc atalyze ammonia elimination from l-phenylalanine more than 4500 times faster than from d-phenylalanine. [1] Moreover, d-phenylalanine wasf ound to be ac ompetitive inhibitor, [1] suggesting that the d-enantiomer can also be bound to PA L. Ar ecent study,i nvolving three PA Ls, suggested that PA Ls are able to catalyze the formation of the d-enantiomers of substrates with an electron-deficient aromatic moiety by as lower and MIOindependent pathway. [20] Awide range of aromatic compounds inhibit PA Ls. The d-phenylalanine is ag eneral inhibitoro fP ALs,a s Scheme1.Three proposed mechanisms for the PA L-catalyzed conversiono fl-phenylalanine to (E)-CA. Ther eaction proceeds via covalent intermediates in A) and B) or through asingle-step transition state in C).
am irror imagepacking is possible.T his was suggested based on similarities in K i value of d-Phea nd K m value of l-Phe. [21] Further kinetic studies investigating protection and inhibition providedm ore evidence on binding of the opposite enantiomers and led to am odels uggesting mirror imagep acking of the substrate enantiomers. [22] Interestingly,i nhibition by SH group-containingc ompoundss eemed to be species specific. [23] Aw ide variety of substrate analogues was studied as inhibitors of PA L in vitro and in vivo for potential herbicide use. [24] Thel argest inhibitory effects were found with 2-aminoindan-2-phosphonic acid (AIP) (K i = 25 nM)a nd (S)-2-aminooxy-3-phenylpropanoicacid (AOPP) (K i = 0.38 nM). [25] Besides kinetic studies,n umerous methodsa re routinely usedt od etermine the binding affinity of small molecules to proteins. Uniquely among the techniques to measurep rotein-smallm olecule interactions,i sothermalt itrationc alorimetry (ITC) stands out, as it directlyp rovides quantitative thermodynamic parameters (DH is directlym easured, K d is calculated from the titration curve,t hen DG and DS are estimated). [26] This method is becoming widely appreciated in measuring the affinity of potential drug candidatest ot heir protein targets. [27] In spite of the usefulness of ITC to assess binding of small molecules to enzymes,t ot he best of our knowledge,n od irect calorimetric measurements were performed for any MIO enzymes.
Here we present detailed enzyme kinetic and equilibriumb inding studies with PALf rom Petroselinum crispum (PcPA L) using three racemic aminophos 
Results and Discussion
Aminophosphonic acids (R)-2,( S)-2 and (AE)-4 are known inhibitors of PA L, [24] and were included in this study for comparative reasons. In compounds 3 and 6 the b-carbon bears instead of hydrogens moieties which can accept attack from nucleophiles from the active site (either the exocyclic methylidene of MIO or ac atalytic tyrosine). Phosphahomocysteine (5)h as in place of the phenyl ring an SH group which may interact with the methylidene group of MIO andt hus inhibit PA L.
On top of the detailed study with PcPA L, the inhibitory behavior of the enantiopure inhibitors [(R)-2, (S)-2 and (R)-3,( S)-3]w as tested with other PALs of eukaryotic andp rokaryotic origin [Rhodosporidium toruloides (RtPA L) and Anabaena variabilis (AvPA L),r espectively].E valuation of the inhibitory properties to these three different PALs offers general insightr egarding the binding stereochemistry and its perturbation by the addition of the methylidene group.
To complete the kinetic studies,w ea lso provide af ull thermodynamic analysisf or these inhibitory molecules to the wildt ype and as pecifically designed Y110F mutant of PcPA L. Modulation of the binding comparedt ot he wild-type protein,e specially with the methylidene-substituted analogues, argues for aspecific interaction between the methylidene moiety and Ty r110 of the mobile,c atalytically relevant loop (called the Ty r-loop). As ITCh as never been applied for MIO enzymes,t he presents tudy contributes to the understanding of the thermodynamics of substrate binding to PA Lwith significant novelty.
Finally,adetailed docking studyo nt he molecular background of the binding of the various compounds to AvPA Lcorroborates these conclusions.
Synthesis of a-Aminophosphonic Acids 2-6
As we aimed for racemic a-aminophosphonic acids and in some cases also their pure enantiomers with ee ! 99% (Supporting Information, FiguresS8-S19), we opted first for the preparation of the racemates.T he enantiomers were obtained by HPLC separationo n ac hiral stationary phase. TMS [28] at 55 8 8Cf or 18 h. Crystallization of the a-aminophosphonic acids from water/i-PrOH gavec olorless crystals of (AE)-3,( S)-(+ +)-3 and (R)-(À)-3 in 61%, 74% and 68% yields,respectively.
Them ixture of Boc-protecteda minophosphonates 7 was converted to racemic 2-propenylphosphonate (AE)-8 in 92% yield using H 2 O 2 (in combination with Me 2 NH having ab eneficial effecto ny ield [29] ). The enantiomers of 8 were separated by preparative HPLC on ac hiral stationary phase (Chiralpak IC column; t R = 15.05 and 30.97 min, both enantiomerically pure). Figure 2A Figure 2B shows the resulto ft he single crystalX -ray structure analysisr evealing that substituted urea (À)-9 hadthe (R)-configuration.T his data corroborated the previous absolute configuration assignment for (R)-(À)-3.
Steady State Inhibition Studies with PcPAL
Initialr eactionr ates for deamination of l-Phe[ ( S)-1] catalyzed by PcPALw ere determined by UV spectrometry detecting the formation of the (E)-CA product at 290 nm.
Initial reaction rates (v 0 )a saf unction of the substrate concentrationd eterminedt he Michaelis constant (K m )a nd the turnovern umber (k cat )o ft he enzyme.K inetic measurements in the presence of inhibitors determinedt he inhibition constants (K i ). The mechanism of inhibition could be determined by comparing the fit of experimental data to different inhibition models. Competitive, uncompetitive andn oncompetitive inhibition models are most commonly found, hence we tested these models in our experiments.W en otet hat the structure of the tested compounds suggests similar binding as the substrate,p otentially resulting in competitive inhibition.
As expected, compound (R)-2 -t he phosphonic acid analogue of the l-Phe[ ( S)-1]-was one order of magnitude stronger as an inhibitor than the opposite enantiomer (S)-2 ( Table 1) . In close agreement with data from the literature, [24] the competitive inhibition model with K i = 0.66 mMf itted best to the experimental data for (R)-2.T he K i = 4.28 mMv alue for (S)-2 was also in agreement with the previous results on inhibition of PA Lf rom maize. [24] Thee nantiomers of aminophosphonica cids 2 and 3 were purified to ! 99.6% ee values (Supporting Information, Figures S17-S19), hence inhibition by contaminatingo pposite enantiomers could be ruled out.
Interestingly,i ntroduction of as ingle methylidene group at the C-2position of phosphonic acid analogue 2 resulting in an ovel inhibitor 3 reversed the enantiopreference of inhibition of PcPA L. In fact, (S)-3 was one order of magnitude stronger as an inhibitor than (R)-3.T he inhibition constant of (S)-3 (K i = 0.04 mM) with PcPALw as only slightly higher than that of AIP -t he most potenta minophosphonic PA Li nhibitor (K i = 0.025 mM). [25] Thef actt hat (S)-3 was two orders of magnitude stronger as an inhibitort han (S)-2,s uggested that the methylidene group had as ignificant effect on binding of the (S)-enantiomers.I nc ontrast, the inhibition constants of (R)-3 and (R)-2 are similar.
Thep henylglycine analogue (AE)-4 was aw eak competitivei nhibitoro fPcPAL. Thec ompetitive inhibition model with K i = 41.5 mM, described best the measured initial reactionr ates (v 0 ). Thea lmosto ne order of magnitude difference compared to previous data [24c] is considerable,n onetheless (AE)-4 was the weakesto ne amongst the effective PA Li nhibitors. Thea romatic binding pocket of PcPA Ls uitedt oa ccommodate ab enzylm oiety seems to be too large for the smallerp henylr ing of (AE)-4,h ence the hydrophobic interactions with the aromaticb inding region of the active site pocket are less pronounced.
In contrast to the preliminary expectations,( AE)-5 and (AE)-6 showedn om easurable inhibition with PcPALu pt o1mM concentration. This is surprising as Pseudomonas putida HAL (sequence identity to PcPAL: 21%) was irreversibly inhibited by l-homocysteinea t9mM concentration after incubationf or 120 min in the presence of oxygen. [30] Initial velocities of the (E)-CA formation with PcPA Lw ere identical when the reaction was started with the addition of PcPALt ot he test in the presence or in the absence of (AE)-5 or (AE)-6 or the enzyme was preincubated with (AE)-5 for 60 min prior to activity measurement. In the case of (AE)-6,t he sterically demanding cyclopropyl substituent at the b-carbon atom presumably hinderedt he binding to PcPA L. This hypothesisw as later supported by molecular docking.
Slow Binding Inhibition of PcPALb yt he Phosphonic Acid Inhibitors (R)-2 and (S)-3
Addition of (S)-3 to the PcPA L-catalyzedr eactionr esulted in non-linear progress curves,a ss hown on Figure 2A, corresponding to ac hange in the enzymatic activity in at ime-dependent manner. Then on-linear rate curves observedo nt he steady-statet ime scale due to transient kinetics suggested as low binding mechanism for the inhibitors. [31] This behavior mayo riginate from different mechanisms at the molecular level:( i) if there is at ransition state-mimicking intermediate,( ii)i ft he inhibitor exists in multiple forms, and only one of which may interact with the enzyme,( iii)i fo nly ar are form of the enzyme binds the inhibitoro r( iv) if after an initial fast binding, slow structural rearrangements form as econd inhibitory complex. [32] In kinetic analysiso f slow binding inhibitors,t he integrated rate equation for the product concentration (P)w as derived by Frieden[Eq. (1)]. [33] This integrated rate equation determinest he velocities at time zero (v z ), the steady-statev elocities( v s ) and the frequency constanto ft he exponential phase (l). Steady state velocities determine the apparent inhibitory constants.T he two simplest slow binging inhibition mechanisms-shown as Eq. (2) and Eq. (3) - Table 1 . Apparent inhibition constants and binding equilibrium constants of the aminophosphonic acids 2-6.
InhibitorT ype of inhibition
[a]
[mM] can be distinguished by the velocities at time zero as afunction of the inhibitor concentration. Accordingt ot he first mechanism representedb y Eq. (2), binding of the inhibitor may be as low process,h ence v z is independent of the inhibitor concentration.A ccording to another slow binding mechanism represented by Eq. (3), an EI complex forms rapidly, which subsequently undergoesc hanges to form the strongly bound (EI)* complex. Due to the first fast step in the second mechanism, v z depends on the inhibitor concentration. Figure 2B shows the first 30 so ft he progress curves of the product formationf rom l-Phec atalyzed by PcPALi nt he absence and in the presence of (S)-3.I t was clearly visible that even the early slope of the curves depended on the inhibition concentrations,a nd the fitted parameters confirmed this observation. This favored the two-step slow binding mechanism describedb yE q. (3), where after an initial fast binding process as low change took place.
Several possibilities could account for this behavior. One possibility mayb et hat deprotonation of the enzyme or the ligand aftert he fast binding enforces the interactions further. As econd possibility may be that in the slow change step an ucleophilic part of the ligand forms aM ichael adduct with the methylidene group of the MIO.F inally,T yr A of the mobilel oop of the enzyme may also attack the methylidene group of the ligand. It is noteworthy that the frequently used AIP also showeds low binding characteristics with PcPAL, howeverb yt he one-steps lowb inding mechanism [Eq. (2)]. [25] Thee nantiopure (R)-2 also showed slow binding behavior, but to as maller extent than (S)-3.I nterestingly,( R)-3 was not as low binding inhibitor. Differences in the binding kineticsi ndicated that although the inhibition constants were almost similar[ K i = 0.64 mMf or (R)-3 and K i = 0.66 mMf or (S)-2], the binding mechanism wasp erturbed by the addition of the methylidene group at the C-2posi-tion.
Decreasesi nt he product formation ratea fter the slow binding step might happen due to an irreversible covalent binding. However, the progress curves determined after preincubation of PcPALw ith (S)-3 suggested reversible binding. Theb lue progress curve with empty circles shown in Figure 3A was obtained in ar eaction startedw ith addition of l-Phe to the assay after preincubation of PcPA Lw ith (S)-3 for 5min. Increases of activity to asteadystate level indicated reversible binding of (S)-3.A dditionally,v ariations of the preincubation time between 1-60min did not alter the progress curves indicating that the fast binding step was completed within 1min.
Inhibition of AvPALand RtPALb y2and 3
In order to ascertain that the effect of the methylidene group on the binding was not PcPALs pecific, but that the enantiomers of 2 and 3 are generalinhibitors of PA Ls,t wo other PALs were tested. In general, MIO enzymes from prokaryotic and eukaryotic sources differ structurally.A lthoughM IO enzymes of both originsh avet etrameric structures,e ukaryotic MIO enzymes contain an additional domaina tt heir Ct erminale nd, rendering eachm onomeric chain longer by approximately 200 amino acids.T hus,i na ddition to af urther PA Lo fe ukaryotic origin (RtPAL, 34% sequence identity to PcPA L), another PA Lo f prokaryotic origin (AvPAL, 27% sequence identity to th data point is plotted). Thec urve in blue with empty dots shows the production of (E)-CA in an assay containing PcPA Lp reincubated with (S)-3 (2 mM). Panel Bs hows the initial part of the progress curves at various inhibitor concentrations (for 0.3 min, for better visibilityo nly production curvesa t1 0mM and 50 mMi nhibitor concentrations are plotted).
PcPAL) wasa lso tested with the enantiomers of aminophosphonic acid 3.
Experiments demonstrated that enantiomers of both 2 and 3 were generali nhibitors of PA Ls.T he enantiopure (R)-2 and (S)-2,f urthermore (R)-3 and (S)-3 inhibited AvPA La nd RtPA Li nasimilar degree as PcPAL( Supporting Information, Tables S10 and S11). Previousr esults showedt hat, althoughA IP has an on-substituted aromaticr ing, it could efficiently inhibit TALa sw ell.
[18a] By analogy,i ti sl ikelyt hat (S)-3 is ag eneral, strong MIO enzyme inhibitor.
Thermodynamics of Ligand Binding to PcPAL
Although ITCp rovedtob eap owerful tool to characterize binding behavior of small molecules to enzymes,t ot he best of our knowledge,n od irect calorimetricm easurements were performed for anyM IO enzymes. During an ITC measurement,aconcentrated protein solution is titrated with small portions of the ligand solution in aw ay that heat changei sm easurable for each injectionp roducing ac urved thermogram [34] (representative thermograms for each measured systema re included in the Supporting Information, Figures S20-S26) . At the beginning of the titration, practically all molecules of the ligandi nt he first injectiona liquots bind to the protein,t hus DH of the binding could be determined. With the addition of further portions of ligand, saturation is reached, the released heat decreases.T he rate of decrease provides the association constant (K a )o ft he binding from which the binding and dissociation constants and DG of the binding can be calculated. TheCparameter determining the curvature (C = [E] K d À1 )i ss uggested to be between 10-1000f or an efficientd etermination of the thermodynamic parameters.I nt he present titration experiments of the non-reactive d-Phe[ ( S)-1], and both enantiomers of the aminophosphonates 2 and 3 with wt-PcPA Ls ufficient heat was generated in all cases, however, in some casesw eak binding of the ligands limited the accurated etermination of the binding enthalpy (Figure 4 ). Due to precipitation, the protein concentration wasl imited to 10 mg mL À1 (0.125 mMo fm onomers). Thus,a ccurate determination of all thermodynamic parameters wasl imited to compounds with specificd issociation constants of less than 12.5 mM( corresponding to C = 10). Although binding entropies could not be determined reliably for C < 10, ITCc an still be usedf or determining dissociation constants and free energies of binding. [35] Comparison of the inhibition constants of both enantiomers of the aminophosphonates 2 and 3 with the binding affinity measured by ITC revealedt hat K valuesd eterminedb yt he twom ethods were in agreement (Table 1) . Reasons of differences could be the different protein concentrations for kinetics and for ITC,o rt he slight difference in the pH (8.8 for kinetics and 8.0 for ITC).
Binding of either enantiomer of aminophosphonic acids 2 and 3 was enthalpy driven (Figure 4 , Supporting Information, Tables S12-S18). Enthalpy contributions of the binding process derive from hydrophobic interactions,h ydrophilic interactions and salt bridges between the ligand and the protein. Then on-significant binding enthalpy difference between (R)-2 and (R)-3 (À0.4 kcalmol À1 )r evealed that the methylidene group had negligible effecto nt he binding affinity of the aminophosphonatesw ith (R)c onfigurations.O n the other hand, the presenceo ft he methylidene group at the C-2 position increasedt he binding enthalpy of the (S)-enantiomer of 3 by 3.1 kcalmol À1 comparedt ot hat of (S)-2.T his effect is in the range of the formation of an additional hydrogen bondb etween the protein and the ligand.
Solvent displacement contributes favorably to the entropyo fb inding. On the other hand, if an initially less ordered region -l ike aloop -a dopts amore rigid conformation, the entropy of the system decreases. Thus,i ns uch an instance the overall binding free energy becomes less negative.T he lowest entropy contributions were determined for the slow binding inhibitors (R)-2 and (S)-3 (À1.2 kcalmol À1 and À0.6 kcalmol À1 ,r espectively). As omewhat larger entropy contributiont ot he binding was observedf or (S)-2 and (R)-3 (À1.7 kcalmol À1 and À2.1kcal mol À1 , respectively). As all of these compoundso ccupy the same binding pocket, the solvent entropy contributions should be equivalentf or their binding. The smallere ntropy contributionw ith the slow binding in- hibitors (R)-2 and (S)-3 is therefore likely due to al arger reduction of the entropyo ft he system by more constraining the flexibility of protein loop(s).
Ad issociation constant of 12.6 mMw as determined for d-phenylalanine [(R)-1]. This value was in the same order of magnitude as K m of l-phenylalanine [(S)-1]. This argued that the same sets of molecular interactions were involvedi nt he binding of l-a nd dphenylalanine to PcPA L. This wasi nf ull agreement with the early model suggestingm irror image packing of the substrate enantiomers within PAL, [22] and directly proved that d-phenylalanine[ ( R)-1]c ould bind to the active site in anon-reactive conformation.
Perturbation of Ligand Binding to PcPALb yt he Y110F Mutation
Thea ctive site of MIO enzymes is covered by as equence of loops,i ncluding the catalytically essential Ty r A residue within the innermost one of them. The possible role of Ty r A in the elimination reaction is shown in Figure 1 . It was shownt hat mutation of Ty r A (at position 110 in PcPAL) to phenylalanine resulted in an inactive protein. [12] By assuming that the Y110F mutation hasn oe ffect on the overall protein structure,t he effect of the mutation on the binding energy can be determined directly using ITC.A st he Y110F mutation led to ac atalytically inactive protein, [12] ITC measurementsw ith this mutant could provide additional details on ligand binding thermodynamics to PcPAL.
TheY 110F mutation in PcPA Lw eakened the binding for all investigatedm olecules (Table 2a nd Supporting Information, Tables S12-S18 ). Comparison of the binding characteristics of several compounds to wt-PcPALa nd Y110F-PcPA Lr evealed ( Table 2) as mall contribution of Ty r110t ot he binding (smaller than requiredf or aw eak hydrogen bond, < 0.8 kcal mol À1 ). Thee ffect of Y110F on the binding of (E)-CA served as ac ontrol. Thep lanar orientation of the bhydrogeno n( E)-CA, andi ts position in the crystal structure [18b] suggest that there is no direct interaction between Ty r110 and the (E)-CA product.T hus,d ifferences in the binding properties of (E)-CA to the two PcPALv ariants quantified the maximum perturbation caused by the Y110F mutation in the binding of substrates with no direct interaction with Y110. Hence, effects with DDG < 0.6 kcal mol À1 could be due to as mall perturbation of the structure and/or natural uncertainty of the experiments.T hus,w ec an only state that the Y110F mutation influences significantly the binding of (R)-2,( R)-3 and (S)-3.
As hift in the equilibrium binding constants demonstrated that Ty r110 is directlyi nvolvedi nb inding of the enantiomericf ormso f3.T he perturbationsi nt he binding free energies [DDG = 2.1 kcal mol À1 for (R)-3 and 0.9kcal mol À1 for (S)-3]w ere in the range of aw eak hydrogen bond. It is also possible that the hydroxy group of Ty r110 formsaMichaela dduct with the methylidene group of 3,w hose formation might be slow,a ccounting for the slow binding behavior of (S)-3.
Thes imilarity of the equilibrium binding constants of the enantiomers of phenylalanine,( R)-1 and (S)-1 (K d = 29.1 mMf or d-Phea nd 23.0 mMf or l-Phe, respectively) to the Y110F-PcPALm utant provided direct evidence for theirm irror imagep acking within PcPAL.
Ty r110-a ne ssential residue in catalysis -l ies in am obile loop region that plays an important role in modulation of substrate binding and product release. [19] Unfortunately,this loop was found in an inactive "loop-out"c onformation within the only currently available crystal structure of PcPAL [36] containing adithiothreitolcovalently bound to MIO.Presumably, as trong interaction of ab ound ligand with Ty r110 can leadt os tabilization of the loop and thus enhance crystallization in acatalytically relevant conformation. Our attempts to crystallize PcPA Li na na po form were unsuccessful, likely due to the high mobility of these loops.H owever, the presenceo ft he strongest binding inhibitor( S)-3 enhanced crystallization of PcPAL, and producedw ell diffracting crystals.A nalysis of the diffraction data is underway; these results will be published in the near future.
Docking of Compounds 1-6 to AvPAL
Molecular docking can contributet ot he understanding of binding of various inhibitors within the PA L active site and can provide data on possible distances between the MIO prosthetic group and various parts Table 2 . Equilibrium binding constants and binding free energy perturbation measured by ITC for the enantiomers of substrate (1), for aminophosphonic acid inhibitors 2 and 3,a nd for (E)-cinnamic acid with wild type PcPA La nd its Y110F mutant.
16.6 À0.6
[a] Differencesi nt he binding free energies show the contribution of the hydroxy group of Ty r110 to the bindinge nergies. DDG = DG wt ÀDG Y110F .
of the ligands.T he ITC results with the Y110F mutant indicated that Ty r110 (Tyr78 in AvPAL) could play an important role not only in the catalysisb ut also in binding of the enantiomericf ormso f3.A st he only crystals tructureo fPcPA L( PDB code:1 W27) [36] containedt he critical Ty r-loop in an inactive conformation, it was essential to find ap roper structural model with ac atalytically capable "loop-in"c onformation of this essential loop.F ortunately,acrystal structure determined for unliganded AvPAL( PDB code:3 CZO) [37] hadt he Ty r-loop in ac atalytically relevant conformation. As the aminophosphonic acid enantiomers 2 and 3 inhibited AvPALs imilarly to PcPAL( see Section 9i nt he Supporting Information), the active site of AvPA L( with the MIO from chain A) was selected as model site for dockingstudies.
Glide algorithmd ocked all compoundsr epresented on Figure 1t ot he structureo fAvPAL. [38] Docking score of Glide (GScore) is an empirical scoring function used for the ranking of the ligand binding conformations (poses). It was developed to approximate the ligand binding free energy and binding affinity prediction. Its numerous termsi nclude force field contributions ando ther terms accounting for interactions known to influence ligandb inding. Values below À7 usuallya gree with acceptable binding.
GScores could differentiate between binding and non-binding compounds.N on-inhibitingc ompounds 5 and 6 docked frequently to the protein surface outside of the active site.E ven if they docked within the active site,t heir GScores were poor( the best GScores inside the active site were À6.2 for 5,a nd À4.2 for 6). In contrast, inhibiting compounds 2, 3 and 4 docked mostly within the active site ( Figure 5 ), andt heir GScores predicted strong binding (lowest GScores were À8.5f or 2, À9.8 for 3 and À8.6 for 4). d-Phe and l-Phe[ ( R)-1 and (S)-1,r espectively] and the product [(E)-CA] docked exclusively inside the active site,w ith good docking scores (GScores were À11.2 for (S)-1, À5.9f or (R)-1,a nd À8.3 for (E)-CA). The absence of the salt bridge between the carboxyl group of (S)-1 and Arg317 of the protein resulted in the poor docking score.G Scores were À9.1 for (S)-1, À10.5 for (R)-1,w hen docked to structure where Ty r78 (Tyr110 equivalent in AvPA L) wasm odelled in the deprotonated form (ligand 1 was docked in the zwitterionic form). Thec arboxyl group of bothe nantiomers of phenylalanine (1)f ormed as alt bridge with Arg317, resulting in significantly better docking scores,a nd indicating the importance of protonation pattern during docking.
Docking poses found for the aminophosphonic acids 2 and 3 revealed poses with the phosphonic acid function of the ligands forming three hydrogenb onds within the carboxylate binding part of the active site within AvPAL. Residues Q311(B), R317(B) and N347(A) located at the carboxylate binding region are conserved in all known PA Ls,a nd also in many other MIO enzymes as well. [19] Panels B, Ca nd Di n Figure 5s how hydrogenb onding of the phosphonic acid functional group of various inhibitors.A pparently,t he larger flexibility of the enantiomers of aminophosphonates 2 and 3 allowst heir mode of binding ( Figure 5B andC ,r espectively) to be similar to that of cinnamic acid [(E)-CA, Figure 5A ] with hydrogen bonding distance to the conserved carboxylate binding residuesQ 311,R 317a nd N347. In contrast, the constrained structure of AIP enforced ad ifferent mode of binding with less interactions to the carboxylate binding residues within aT AL structure ( Figure 5D) .
Docking found no significant differences for the different enantiomers of 2 and 3,a nd could not accountf or the direct effect of the methylidene group on the binding free energies.T his suggestst hat these differencesa re due to differences in the protonation state patternsand/or inducedfitting effects of the protein structure.
Figure5.Ligand bindingw ithin PA Ls.D ockingr esults (within apo AvPA L, in grey) are compared to ligands bound to crystal structures (in green). Panel As hows (E)-CA within ac omplexed structure of AvPA L( PDB code 3NZ4, [9] in green) overlaid with (E)-CA (in magenta) docked into apo AvPA L( PDB code 3CZO,i ng rey). Panel Bd epicts the poses of (R)-2 (cyan) and (S)-2 (yellow) with the best docking scores within AvPA L( in grey). Panel Cs hows the poses of (R)-3 (cyan) and (S)-3 (yellow) with the best docking scores AvPA L( in grey). Panel Ds hows the binding of AIP within ah omologousp rotein structure (PDB code 2O7E, [18a] in green).
Conclusions
Synthesis of ande nzyme kinetic and calorimetric studies with racemic and enantiopure aminophosphonica cids 2-6 as specific inhibitors of phenylalanine ammonia-lyase andf urther MIO enzymesp rovided significant insights into the details of ligand binding to PA L. Here we propose that for MIO enzymes having synthetic importance eveno na ni ndustrial scale,c ompound (S)-3 may act as general inhibitor with comparable inhibition to the less substratelike AIP which is the strongest aminophosphonic acid-type inhibitorfor MIO enzymessof ar. This compound binds by an interesting slow binding mechanism, that may be due to Michaela dduct formation with Ty r110a nd/or to the sequential to stabilization of the Ty rl oop.
Our studyi ndicated for the first time that isothermal titration calorimetry( ITC) could provide valuable information for ligandb inding to PA La nd further MIO enzymes as well. With the aid of suitable point mutations -s uch as the Y110F mutation in PcPAL-ITC was capable of estimating the contribution of an individual residue and thus provided significant contribution to the understanding of ligand binding. By ITC with the catalytically inactive Y110F-PcPA L, we could directly prove that the non-reactive d-phenylalanine (R)-1 binds to PcPA La lmosta ss trong as the natural substrate l-phenylalanine (S)-1.
Althoughc ompound (S)-3 is aw eaker inhibitor than l-AOPP,anon-aminophosphonic acid-type transition state-mimicking compound being the strongest inhibitoro fP ALs,b ut it is also less sensitive and less reactive. Therefore,( S)-3 may have high potential in ligand binding and structural studies of MIO enzymes. Theu sefulness of (S)-3 in structural studies wasi ndicated by the formationo fw elld iffractingc rystals of PcPALi nt he presence of the strongest binding inhibitor, whilet rials to crystallize PcPALi ni ts apof orm were unsuccessful. Moreover, similarly to AIP,b oth enantiomers of 3 could be further investigated as promising potential herbicide candidates. 
Experimental Section

ProteinProduction and Purification
PcPA L( Uniprot code:P 24481) was produced by heterologous expression in E. coli-Rosetta, and was purified with Niaffinityc hromatography,a sd escribed by Dima et al. [39] The Y110Fm utanto fPcPA Lw as createdb ys ite-directed mutagenesis followingt he protocold escribed by Naismitha nd Liu [40] using the forward primer: CTGACTCCTTCGGAGTAAC TACTGGATTCGGAGCCACT and reverse primer: GTTACTCC GAAGGAGTCAGTTCCCTTGTTCATGGATCC.M utagenesis was verified by sequencing using T7-for CAGAACAT TACTCCCTGCTTG and T7-rev TTGACGTATCCAGAAACAAGG primers.B oth primers and sequencing were performed at the Sequencing Service of Genomed (Debrecen, Hungary). Thel ength of the insert requiredt he use of fourp rimers to cover the whole transcribedD NA region. Protein production and purification followed the same protocol as used for PcPA L. [39] AvPA L( Uniprot code:Q 3M5Z3;w ith two surface cysteines mutated to serine,C 503S,C 565S) and RtPA L( Uniprot sequence code:P 11544) were produced and purified using as imilar procedure as described for PcPA L.
Kinetic Assays
Initialr eaction velocities of the PA L-catalyzed reaction of l-phenylalanine[ ( S)-1]w ere determined in 100 mM TRIS, pH 8.8 at 30 8 8C, using 0.01 mg mL À1 PcPA Lb ym easuring the (E)-cinnamic acid formationa t2 90 nm in aU V/Vis spectrophotometer (Specord 200;A nalytic Jena AG,J ena, Germany). Thee xtinction coefficient for (E)-cinnamic acid was determined by 7-point calibrationu sing (E)-CA solutions in 100 mM TRIS (pH 8.8 at 30 8 8C). To determine the Michaelis constant and the turnover number, initial velocities were measured at nine substrate concentrations between 75 mMa nd 10 mM. Inhibitionc onstants for the aminophosphonica cids 2 and 3 were determined by measuring the initial product formationrates at the same substrate concentration in the presence of the inhibitor. When the regression coefficient of the linear fit (R 2 )w as lower than 0.999,i nt he slow binding experiments with (S)-3 and (R)-2,the combination of al inear and an exponentiale quation was fit to describe the productionc urves.S teadys tate velocities were used for determiningt he inhibition constant values.A ll measurements were performed twice.
Non-inhibited kinetic parameters were obtainedb yf itting the Michaelis-Menten equation to all data points using the nls (non-linear least squares)f it in program R [41] (with keeping all settingsa ttheir default values). Themechanism of inhibitionwas determined by fitting the competitive,non-competitive and uncompetitive inhibition models to the measured data. Thel owest value of the residuals indicated the best fitting model,a nd thus the mechanism of the inhibition. Visual comparison of the fitted curves to the experimental data confirmed in all cases the choice of mechanism.
Isothermal Titration Calorimetry
ITC measurements were performed in am icrocalorimeter (MicroCal 200;G EH ealthcare,C hicago,U SA). Protein sol-utions ( % 100 mMm onomer units of PcPA L) were titrated with 5t imes more concentrated ligand solutionsu sing 20-25 injections.I nitiald elay,a nd time between two injections was set to 180 s. Binding was measured at 30 8 8Ci nT RIS (50 mM, pH 8.0, containing 1mMo ft ris(2-carboxyethyl)-phosphine,TCEP).
Titrationc urves were analyzedu sing the softwarea nd methods described by Brautigam et al. [42] Thermograms were integrated using NITPIC. [43] Binding thermodynamic data were determined by fitting the A + + Bh eteroassociation model in SEDPHAT. [44] Confidence intervals for DH, K d and the stoichiometry of the binding were calculated at p values corresponding to one s level. Thec onfidence interval of K d determined the one for DG,w hile the minimal and maximal differences between the DH and DG confidence intervals yielded the one for ÀTDS. Data were plotted using GUSSI. [45] Molecular Docking Prior to docking, hydrogensw ere added to the structure of AvPA L, and their positionswere optimized using the Protein Preparation Wizard in Maestro. [46] Protonation states of the amino acid residues at pH 8.8 were set on the basis of pK a estimation by ProPka. [47] Docking was carried out using ar igid protein model with af lexible ligand, by extra precision docking in Glide. [38] The center of mass of the ligand was restricted to a20 20 20 box centered on the midpoint between the MIO residue and Ty r78 of the tyrosine loop.T he entire ligand was restricted to al arger 40 40 40 box centered at the same midpoint. Thev an der Waals (vdW) radii of the hydrophobic residues (partial charge less than 0.2) were scaled down to 80%. This reduced vdW radii of the hydrophobic residues approximated as mall degree of enzymef lexibility.T he vdW radii of the ligands were not scaled. Foro ther dockings ettings the default valuesw ere kept. Ligand poses that encountered steric clashes,d efined as as um of Coulomb and vdW interactions energies > 10 kcal mol À1 ,w ere discarded. Duplicate poses,d efined by an RMS deviation less than 1.0 or by am aximum atomic displacement less than 1.5 from existing poses,w ere also discarded.
